Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease.

Vickers, Mark A

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease. [electronic resource] - British journal of haematology Nov 2014 - 402-10 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1365-2141

10.1111/bjh.13051 doi


Adolescent
Allografts
Central Nervous System Neoplasms--therapy
Child, Preschool
Epstein-Barr Virus Infections--immunology
Female
HLA Antigens--analysis
Herpesvirus 4, Human--immunology
Histocompatibility Testing
Humans
Immunotherapy, Adoptive
Infant
Leiomyosarcoma--therapy
Licensure
Lung Neoplasms--therapy
Lymphoproliferative Disorders--etiology
Male
Middle Aged
New Zealand
Postoperative Complications--immunology
Remission Induction
Sarcoma--therapy
T-Cell Antigen Receptor Specificity
T-Lymphocytes, Cytotoxic--immunology
Tissue Banks--organization & administration
Treatment Outcome
Young Adult